Drugs / Shigella Sonnei O-SPC/rBRU
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01369927 | May 2011 → Apr 2013 | shigellosis | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shigella Sonnei O-SPC/rBRU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01369927 ↗ |
| Modality | Vaccine | “Shigella sonnei O-SP-core conjugate vaccine” NCT01369927 ↗ |
| Route | Intramuscular | “one i.m. injection of 10 or 25 micrograms of the investigational conjugate vaccine” NCT01369927 ↗ |